Emami Limited has initiated the acquisition of a 73.5% stake in Axiom Ayurveda Private Limited (AAPL). By completing the first tranche of the purchase, Emami has increased its total holding and successfully transitioned AAPL into a subsidiary. The remaining portion of the acquisition is expected to be finalized by June 2026, solidifying the company’s control over the ayurvedic brand.
Strategic Business Expansion
In a significant move to bolster its presence in the wellness and ayurvedic market, Emami Limited has entered into a Share Purchase Agreement to acquire 73.5% of the paid-up capital of Axiom Ayurveda Private Limited (AAPL). Previously an associate entity with a 26.5% stake, AAPL is now officially a subsidiary of Emami Limited.
First Tranche Completion
The company confirmed that the first phase of this transaction was completed on April 1, 2026. This initial step involved the acquisition of 84,30,909 equity shares, representing approximately 36.7% of the total stake. This critical milestone marks the transition of AAPL from an associate to a subsidiary, allowing for deeper integration of operations.
Future Outlook
Following the successful first tranche, Emami Limited is set to acquire the remaining 84,30,909 equity shares to complete the full 73.5% stake purchase. The finalization of this agreement is scheduled to take place by June 2026. This acquisition aligns with the company’s broader strategy to expand its portfolio and strengthen its market reach within the consumer healthcare segment.
Source: BSE
